Infections by
Pseudomonas are commonly encountered in the field of otorhinolaryngology. In most patients, the infection is localized and does not become severe, but the disease is often refractory to chemotherapy and thus local infection persists. On the other hand, although the incidence is very low, the infection may become so severe as to require intensive care. It is considered to be clinically important to be able to forecast possible aggravation of
Pseudomonas infections by investigating why the disease is sometimes refractory to chemotherapy.
In spite of the fact that many strains of
P. aeruginosa are sensitive to serum bactericidal activity, infections by this bacterial species are sometimes refractory to chemotherapy and persist locally. In order to elucidate the mechanism of this refractory nature, the author investigated the effect of pus present in the focus of the lesion on the serum bactericidal activity against
P. aeruginosa and compared the serum bactericidal activity against this bacterial species among patients infected with
P. aeruginosa, patients with other diseases and healthy persons. On the basis of these investigations, the author studied whether or not it is possible to forecast the possibility of aggravation of
P. aeruginosa infections.
The following results were obtained.
1. Complement is thought to play an important role in the serum bactericidal activity against
P. aeruginosa.
2. It was found that the pus in the lesions of patients with
P. aeruginosa infections contains, in addition to the cells of the bacterium itself, some substance which is thought to inactivate the bactericidal activity of the serum.
The patients with
P. aeruginosa infections, except for one patient, also had serum bactericidal activity against
P. aeruginosa, the same as the healthy persons. Among the patients investigated, only one patient, who had anamnesis of malignant external otitis, did not have any serum bactericidal activity against
P. aeruginosa.
The above findings indicated that infections by
P. aeruginosa or its clinical course may become aggravated if the patient's serum bactericidal activity against this bacterium is low.
View full abstract